Walvax Biotechnology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Wei Yao
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Does Walvax Biotechnology (SZSE:300142) Have A Healthy Balance Sheet?
Mar 14
Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Share Price Not Quite Adding Up
Jan 18We Think Walvax Biotechnology (SZSE:300142) Can Stay On Top Of Its Debt
Nov 25Some Confidence Is Lacking In Walvax Biotechnology Co., Ltd.'s (SZSE:300142) P/S
Sep 24Is Walvax Biotechnology (SZSE:300142) A Risky Investment?
Jun 19Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Prospects Need A Boost To Lift Shares
May 23There May Be Reason For Hope In Walvax Biotechnology's (SZSE:300142) Disappointing Earnings
Apr 07Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 02Is Walvax Biotechnology (SZSE:300142) A Risky Investment?
Mar 01CEO
Wei Yao (52 yo)
Mr. Wei Yao is President of Walvax Biotechnology Co. Ltd. from 2024. Mr. Yao was Marketing Director of Walvax Biotechnology Co. Ltd.from August 12, 2016 to 2024.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.83m | no data | |
| Vice Chairman & VP | 3.3yrs | CN¥2.05m | no data | |
| Chief Financial Officer | less than a year | CN¥313.20k | no data | |
| Director of Operations | 7.6yrs | CN¥1.10m | 0.042% CN¥ 7.0m | |
| Board Secretary | 2.6yrs | CN¥1.07m | no data | |
| Engineering Director | 1.8yrs | CN¥1.11m | no data |
Experienced Management: 300142's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | less than a year | CN¥1.83m | no data | |
| Vice Chairman & VP | 3.3yrs | CN¥2.05m | no data | |
| Chairman | 15.9yrs | CN¥2.84m | 1.7% CN¥ 282.4m | |
| Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Chairwoman of the Supervisory Board | 4.8yrs | no data | no data | |
| Non-Independent Director | 4.8yrs | CN¥120.00k | no data | |
| Director | 3.5yrs | CN¥234.00k | 0.0044% CN¥ 728.5k | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Independent Director | 2.6yrs | CN¥120.00k | no data | |
| Employee Supervisor | 2.6yrs | no data | no data |
Experienced Board: 300142's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/21 20:52 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Walvax Biotechnology Co., Ltd. is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Tong Zhang | China Merchants Securities Co. Ltd. |
| Ling Bo Tu | China Minzu Securities |